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Transient minimal hydronephrosis on contralateral kidney in infants with unilateral
hydronephrosis: Is it an early sign of worsening of the affected kidney?
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Background/aim: The criteria for surgical management of ureteropelvic junction obstruction are not well-defined, and there is a risk
for loss of renal function before the operation. In this context, certain changes in contralateral kidney had been investigated in order
to increase the sensitivity of diagnosis. In this study, we aimed to investigate whether contralateral transient minimal hydronephrosis
(CTMH) can be considered as an “early alarm” sign for worsening of the affected kidney in infants with hydronephrosis.
Materials and methods: A total of 182 infants (92 surgically treated and 90 conservatively followed-up) with unilateral hydronephrosis
were retrospectively analyzed. Ultrasonography and renal scan findings were evaluated. Correlation between the appearance of CTMH,
contralateral compensatory hypertrophy (CCH) on ultrasonography, and prognosis of the affected kidney were evaluated.
Results: Among the surgically treated patients, 18 (19.6%) patients developed CTMH on average 7 months (0–13 months) before
surgery. Among these 18 patients with CTMH, 12 patients (66.6%) had loss of renal function preoperatively, while this ratio was 29.7%
on their counterparts (p = 0049). CCH was observed in 31 (33.7%) individuals in surgically treated patient group including all 18
patients with CTMH, while none of the conservatively followed-up patients developed CCH and/or CTMH. In the multiple logistic
regression analysis, among the variables investigated, CTMH was found as an independent predictor of the deterioration in the affected
kidney and of the poor prognosis (p = 0.011 and p = 0.0004, respectively).
Conclusion: In our study, among the variables investigated, CTMH was found as an independent predictor of the deterioration in
the affected kidney and poor prognosis in infants followed-up with isolated unilateral hydronephrosis. Additionally, CTMH can be
considered as an “early alarm” sign for worsening of the affected kidney and the need for surgical intervention.
Key words: Infant, compensatory hypertrophy, transient hydronephrosis, ureteropelvic junction obstruction

1. Introduction
Hydronephrosis (HN) is the most common urinary tract
pathology detected in the prenatal period. Some of the
patients with prenatally diagnosed HN have ureteropelvic
junction obstruction (UPJO) and need surgical intervention
[1]. As none of the available investigations can make a definite
diagnosis of urinary obstruction, differentiation between
obstructive (UPJO) and non-obstructive HN is usually made
according to clinical findings and anatomical or functional
status of affected kidney [2–5]. In this context, changes in
the contralateral kidney have also been investigated in order
to increase the sensitivity of the diagnosis [6].

In this retrospective study, we described “contralateral
transient minimal hydronephrosis” (CTMH) as a new
clinical phenomenon and investigated its relation with
functional changes in the affected kidney in unilateral
hydronephrosis cases.
2. Materials and methods
After the approval of the ethics committee, medical records
of patients below 1 year of age who were presented with
HN between the years 2005 and 2016 were retrospectively
reviewed. A total of 182 patients with isolated HN were
included. According to treatment, the patients were divided
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into two groups as surgically-treated and conservatively
follow-up patients. All clinical features including age,
sex, age of presentation, age of operation, ultrasound
examination of the affected and contralateral kidney, and
scintigraphy findings were collected from patient files.
2.1.
Determination
of
follow-up
protocols,
ultrasonographic (US), scintigraphic examinations
All patients were evaluated by the Pediatric NephroUrology Council (Pediatric Urology, Nephrology,
Radiology and Nuclear Medicine specialist) of our hospital.
The imaging modalities and timing were discussed and
decided individually.
For anatomical parameters, detailed US examinations
were performed by the same pediatric radiology team, and
the same parameters such as HN grade [SFU (Society of
Fetal Ultrasound) grade], renal pelvis anterior-posterior
diameter (RPAPD), parenchymal thickness, parenchymal
echogenicity,
corticomedullary
differentiation,
uroepithelial thickness had been evaluated and reported.
None of the patients were hydrated intravenously before
US examinations.
The percentile values of the kidneys for evaluating
CCH were calculated using Multivariable Pediatric Renal
Nomogram based on the studies of Chen et al [7,8].
Contralateral compensatory hypertrophy was defined as
the kidney length above the 95th percentile of normal length
according to age, sex, and height. Minimal hydronephrosis
was defined as SFU Grade I-II hydronephrosis (RPAPD
ranged 5–10 mm) of the contralateral kidney. Minimal
hydronephrosis during full bladder and/or which did
not persist at the end of the examination was not selected
as minimally HN. Contralateral transient minimally
hydronephrosis was defined as a minimally HN, which
was not present initially, developed during follow-up
and regressed by time. Progressive hydronephrosis was
defined as an increase in RPAPD and caliceal diameter,
parenchymal echo deteriorations, and parenchymal
thinning in consecutive ultrasonography examinations.
For functional status of the kidneys, Tc-99m DMSA or
Tc-99m MAG-3 scintigraphy was performed in selected
caseses depending on the severity of HN and clinical
symptoms. Although scintigraphy selection used to be
determined by the availability of the material and the age of
the patient, MAG-3 was preferred in our clinic afterwards.
Preoperative DRF < 40% was defined as a decreased renal
function. Loss of renal function was defined as >10% loss
of DRF in consecutive scintigraphy. At least 10% reduction
in DRF and/or deterioration in HN following the operation
was identified as postoperative poor outcome.
Except for emergency surgical/interventional
indications such as severe HN presented with palpable
abdominal mass or urinary infection with pyonephrosis,
surgical indications for pyeloplasty include progressive
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HN, loss of renal function and the presence of symptoms
during follow-up. Decreased DFR or severe HN alone at
clinical presentation did not indicate surgery.
2.2. Statistical analysis
Statistical analyses were performed using Statistical
Package for Social Sciences (SPSS) version 22.0 (SPSS
Inc., Chicago, IL, USA). The Kolmogorov–Smirnov test
was performed to assess normal distribution. Parametric
variables were analyzed by independent t-test and nonparametric variables by Mann–Whitney U test. The
homogeneity of variance was determined by the Levene
test. To compare qualitative variables, Chi-square test
with Fisher exact test correction was used. The Pearson
correlation coefficient was used to measure the strength
of a linear association between two variables. Forward
multiple regression was used for multivariate analysis,
which included only variables that reached statistical
significance in univariate analysis. The level of statistical
significance was set at p < 0.05.
3. Results
A total of 182 (132 male, 50 female) patients with unilateral
HN (122 left kidneys, 60 right kidneys) were included.
During follow-up, 92 patients underwent surgical repair of
UPJO and unilateral pyeloplasty was performed. Surgical
indications of these patients were as follows: progressive
HN in 44 patients, loss of renal function in 31 patients, and
the presence of symptoms in 17 patients. The median age
of patients was 9 (range: 0 – 365 days) days at the time of
diagnosis of HN and 7 (range: 6 days–36 months) months
at the time of the surgery. The mean postoperative followup period was 44.7 (12–99) months for the surgicallytreated group.
According to clinical and radiologic findigs at
diagnosis and during follow-up, 90 patients were treated
conservatively, and these patients constituted the followup group. The median age of the follow-up group at the
time of diagnosis of HN was 4 (range: 5 days–12 months)
months. The mean follow-up period was 50.5 (range: 12–
72 months) months. Comparative data of these two groups
are summarized in Table 1. There was no statistically
significant difference between groups in terms of age, sex,
side of hydronephrosis, and duration of follow-up.
Contralateral transient minimal hydronephrosis
was detected in 18 (9.9%) patients during follow-up.
The CTMH emerged at the median age of 3 (range: 2–8
months) months and disappeared within an average of
5 (range: 2–10 months) months. Renal pelvis anteriorposterior diameters, SFU grades of these intact kidneys,
bladder volume during examination, and RPAPD changes
of the affected kidneys before and during this period are
shown in Table 2. All these patients were in the surgically
treated group (18/92, 19.6%). RPAPD in the affected
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Table 1. Demographic, anatomic, and functional values of the patients undergoing surgical intervention and conservatively
followed.
Surgically-treated group
(n = 92)

Conservativelly follow-up group
(n = 90)

Median age at diagnosis

9 (0–365) days

4 (5 days–12months) months

Male/Female

3.1/1

2.9/1

Follow-up period

Mean: 44.7 (12–99) months

Mean: 50.5 (12–72) months

Side of HN

Left N: 62 (67.4%)
Right N: 30 (32.6%)

Left N: 60 (67%)
Right N: 30 (33%)

SFU Grade of HN (n )
Grade I:
Grade II:
Grade III:
Grade IV:

0
0
66
26

0
56
34
0

Initial scintigraphy (n)
DMSA
MAG-3

52
32

6
6

Postoperative scintigraphy (n)
DMSA
MAG-3

36
36

-

Contralateral compensatory hypertrophy, n (%)

31 (33.7)

0

Contralateral transient minimally HN, n (%)

18 (19.6)

0

HN: Hydronephrosis, DMSA: Dimercaptosuccinic acid scintigraphy, MAG-3: Mercaptoacetyltriglycine scintigraphy.

kidney tended to decrease when CTMH was developed
(Table 2). A mean of 7 (0–13) months after the emergence
of the CTMH, the affected kidney was referred for surgery
(Figure). Median age at the time of surgery was 10 (5–
16) months. None of the patients in follow-up group
developed CTMH during a mean duration of 50.5 months.
Preoperative loss of DRF rate was 66.6% (12/18) in
CTMH (+) patients, while it was 29.7% for the rest of
the patients (Table 3). Despite a successful operation
(no perioperative and postoperative complications, no
postoperative urinary tract infection and no sign of
obstruction in Tc-99m MAG-3 scintigraphy), six patients
had postoperative loss of DRF (Table 2 and 3).
Contralateral compensatory hypertrophy was
developed in 31 (17%) patients during follow-up. The
CCH was diagnosed at the median age of 9 (range:
2–16) months. The percentile values of the contralateral
kidneys at the presentation were 80 and below (5–80),
while it was 95 and above (95–100) after compensation.
All these patients were in surgically treated group (31/92,
33.7%) and 18 (58%) of them were CTMH-detected cases
previously. The median time between CTMH detection
and CCH development was 5.5 (range: 2–10) months.
None of the patients in the follow-up group developed
CCH during follow-up.

A univariate analysis determined the following risk
factors of the deterioration in the affected kidney: CCH
and CTMH. In a multiple logistic regression analysis,
CTMH was found to be the only independent predictor of
deterioration in the affected kidney in the infants followed
up with isolated hydronephrosis and poor prognosis (p =
0.011 and p = 0.0004, respectively) (Table 4).
4. Discussion
Both anatomical and functional findings of affected
kidneys at diagnosis and during follow-up are the main
criteria for differentiating obstructive pathologies in
prenatal hydronephrosis. On the other hand, obstruction
does not only affect the ipsilateral kidney but it also causes
significant changes in the contralateral kidney. These
changes are the possible result of functional disorders in
the affected kidneys, and it is a well-known condition.
Hinman termed this condition as a “renal counterbalance”
[9]. Renal counterbalance is the response of the
contralateral kidney to the reduction of the number of
functional nephrons in the affected kidney. Starting from
this point of view, it seems logical to consider that various
detectable changes in the contralateral kidney might be an
indicator of functional changes in the affected kidney. Koff
et al. pointed out that CCH can be an early sign of reduced
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Table 2. Ultrasonographic and scintigraphic findings of the patients with CTMH.
RPAPD (mm)/ SFU Grade of
contralateral kidney during
emergence of CTMH

Bladder volume
(cc) during the
USG

Renal RPAPD changes of the
Pre-op DRF of
affected kidney; before and during affected kidney
emergence of CTMH (mm)
(%)

Post-op DRF of
affected kidney
(%)

1

6/I

2

40–30

39

21.8

2

9/II

10

25–17

42

50

3

6/I

empty

20–17

45

43

4

8.3/II

empty

20–15

44.5

32

5

5.9/I

empty

39–30

52

40.8

6

7/I

empty

30–30

40

-

7

5/I

5

25–35

40

30

8

10/II

6

45–40

44.6

55

9

7.3/I

empty

50–15

32

30

10

10/II

empty

25–30

28

27

11

5.8/I

10

20–15

49

33.4

12

10.5/II

2.5

28–28

49

48

13

5/I

2

25–35

44.5

55

14

5.4/I

empty

25–15

39

49

15

9/II

empty

30–20

46.7

45

16

8/II

empty

30–30

42

45.4

17

9/II

empty

37–20

13

9

18

5.5/I

empty

35–25

36

18

RPAPD: Renal pelvis anterior-posterior diameter, CTMH: Contralateral transient minimally hydronephrosis,
CCH: Contralateral compensatory hypertrophy, DRF: Differential renal function.

Figure. The time relationship between CCH, CTMH, and operation. TMH: Transient minimally
hydronephrosis, CCH: Contralateral compensatory hypertrophy, DRF: Differential renal function.

function in the affected, hydronephrotic kidney with
obstruction [6]. On the other hand, Brandell et al. reported
that CCH was a common finding that might have been
manifested without any functional loss in hydronephrotic
kidney and should not be used as an auxiliary finding

2032

in the follow-up and management of a hydronephrotic
kidney [10]. In our series, 31 of 92 patients who underwent
surgery had developed CCH on contralateral kidney, while
none of the patients, who were followed-up conservatively,
developed CCH on serial US exams. All 31 patients with
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Table 3. The comparison of renal functional and ultrasonographic outcomes in patients with and without CTMH.
Patients with CTMH
n = 18

Patients without CTMH
n = 74

P value

Compensatory hypertrophy, n (%)

18 (100)

13 (17.5)

0.00001

Preoperative SFU Grade, n (%)
Grade III:
Grade IV:

11 (61)
7 (39)

55 (74)
19 (26)

0.38
0.38

Preoperative mean DRF, %

34.6 (9–49)

45.6 (28–58)

Preoperative decrease in DRF, n (%)

12 (67)

21 (30)

0.0049

Postoperative decrease in DRF, n (%)

6 (33)

0 (0)

0.001

CTMH: Contralateral transient minimally hydronephrosis, DRF: Differential renal function.
Table 4. Univariate and multivariate logistic regression analyses for the deterioration in the affected kidney in the infants followed up
for isolated hydronephrosis.
Variables

Univariate analysis

Multivariate analysis

OR

%95 CI

P

Age

1.01

1.001–1.019

0.56

Sex
Laterality

1.567

0.551–4.452

0.399

0.611

0.206–1.814

0.375

Time between presentation and operation

0.984

0.956–1.014

0.302

Preop SFU

1.692

0.628–4.563

0.299

Preop APD

1.003

0.963–1.045

0.889

Preop Parenchymal Thickness

1.002

0.814–1.235

0.982

Preop DRF

0.957

0.901–1.017

0.157

CCH

4.83

1.257–18.624

0.031

CTMH

13.158

1.442–120.070

0.022

OR

%95 CI

P

21.171

2.021–221.7

0.011

APD: Renal pelvis anterior-posterior diameter, DRF: Differential renal function, CCH: Contralateral compensatory hypertrophy,
CTMH: Contralateral transient minimally hydronephrosis.

CCH were operated according to our surgical indication
criteria, and UPJ obstruction was confirmed by both
retrograde urography and operative findings. In addition,
CCH was found to be associated with functional defects
of the affected kidney (67% of patients) and, in 18 of these
patients, there was loss of function preoperatively. Our
study also supports the finding that CCH is associated
with worsening of the affected kidney (p = 0.0017).
There were 18 patients in our series who developed
contralateral minimally hydronephrosis during followup. The previous examinations of these kidneys did
not show any sign of HN and/or calyceal enlargement,
neither did the patients hydrated intravenously prior
to US investigation. Moreover, all patients had at least
one normal ultrasonography report after neonatal

period. The median age of the patients at diagnosis of
contralateral minimally hydronephrosis was 3 (range:
2–8) months. Since this USG finding was disappeared
in all patients within a median 5 (range: 2–10) months
period, it was named as “contralateral transient minimally
hydronephrosis”. Although CTHM appears to be a harmless
clinical finding, we have documented several clinically
significant changes in both affected and contralateral
kidneys associated with CTHM. Firstly, all these patients
developed CCH on average 5.5 months after the onset
of CTMH and CTMH regressed immediately after the
development of CCH. Secondly, all patients with CTHM
were underwent surgical treatment for UPJO within an
average of 7 (2–13 months) months after the emergence of
CTMH. Thirdly, all these patients had preoperative renal
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deterioration on the affected kidney. When we evaluate all
these findings, it seems that there is a clinical sequence in
some of unilateral HN cases. During the clinical course of
these cases, CTMH develops first. Then, CCH emerges,
and CTMH disappears shortly after the emergence of
CCH. This process is followed by ipsilateral renal failure/
loss of function and surgical treatment (Figure).
All these changes can be explained by the effects
of partial/chronic urinary obstruction on renal
hemodynamics and functions. In guinea-pig models,
the renal blood flow of the affected kidney can be halved
due to chronic ureteral obstruction [11]. This condition
leads to decrease in the number of perfused glomeruli in
obstructed kidneys [12]. At the same time, renal blood
flow on the contralateral kidney increases while unilateral
urinary obstruction occurs. More interestingly, renal blood
flow may increase even before any changes are detected in
the obstructed kidney [13]. Up to 3 weeks, the number
of perfused glomeruli are increased in the contralateral
kidney, and this effect is the main reason of hyperfiltration
of the nephrons [11]. The filtration rate of the intact/
contralateral kidney increases in proportion to the loss
of function in the obstructed kidney. This means that
the higher the loss of function of the diseased kidney, the
higher the GFR and urine production of the contralateral
kidney, which possibly causes minimally HN at the
beginning and then results in compensator hypertrophy.
Secondary HN caused by increased urine flow and
higher pressure in the collecting system is well documented
in the literature [14]. This condition is also seen in some
cases with nephrogenic diabetes insipidus [15].
In our series, patients who developed CTMH and
CCH constituted a small proportion of patients treated
surgically (19.6% and 33.7%, respectively). The most
important question at this point is that why all surgicallytreated patients that have proved urinary obstruction
did not develop CTMH and/or CCH. Since our study is
retrospective, it is not possible to explain this question
with our findings. But we may argue that some of CTMH
cases were missed because of a short period between the
appearance and disappearance of CTMH. This period can
meet the period between the follow-up USGs. Another
argument might be that the different severity and/or
nature of UPJO may determine CTMH development.
Among 90 patients in the follow-up group, CTMH was
not detected, and all patients with CTMH were underwent

surgery. This finding supports that CTMH is closely
related with severe urinary obstruction. To the best of
our knowledge, CMH was not previously described in the
literature and can be the earliest sign of the worsening of
the affected kidney.
The retrospective nature of the study, the small number
of patients with CTMH, and the comparison of different
renal functions according to Tc-99m DMSA and MAG3 data in some patients are the main limitations of this
study. Our results need to be strengthened by larger series
of patients and prospective studies.
In conclusion, the results of our study support the
association between the deterioration of the affected kidney
and contralateral transient minimal hydronephrosis.
Among the variables investigeted, CTMH was found to
be an independent predictor of the deterioration in the
affected kidney and poor prognosis in infants who are
followed-up with isolated unilateral hydronephrosis.
Contralateral transient minimal hydronephrosis can
predict the gradual loss of DRF on the affected kidney,
and, together with clinical and other laboratory findings,
it can also predict the need for surgical intervention
before contralateral renal injury develops/worsens. This
leads us to believe that contralateral transient minimal
hydronephrosis can be considered as an “early alarm” sign
for both worsening of the affected kidney and the need of
surgical intervention.
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